Abbruzzese JL - Search Results

1

Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer.

Hoff PM, Wolff RA, Xiong H, Jones D, Lin E, Eng C, Dutta A, Bogaard KR, Abbruzzese JL. Hoff PM, et al. Among authors: abbruzzese jl. Cancer. 2006 May 15;106(10):2241-6. doi: 10.1002/cncr.21874. Cancer. 2006. PMID: 16598762 Free article. Clinical Trial.

2

Synergistic cytotoxicity with 2'-deoxy-5-azacytidine and topotecan in vitro and in vivo.

Anzai H, Frost P, Abbruzzese JL. Anzai H, et al. Among authors: abbruzzese jl. Cancer Res. 1992 Apr 15;52(8):2180-5. Cancer Res. 1992. PMID: 1373105

3

Studies on the mechanism of the synergistic interaction between 2'-deoxy-5-azacytidine and cisplatin.

Abbruzzese JL, Frost P. Abbruzzese JL, et al. Cancer Chemother Pharmacol. 1992;30(1):31-6. doi: 10.1007/BF00686482. Cancer Chemother Pharmacol. 1992. PMID: 1375133

4

Phase II trial of fazarabine in advanced colorectal carcinoma.

Hubbard KP, Daugherty K, Ajani JA, Pazdur R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: abbruzzese jl. Invest New Drugs. 1992 Apr;10(1):39-42. doi: 10.1007/BF01275479. Invest New Drugs. 1992. PMID: 1376722 Clinical Trial.

5

Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.

Pazdur R, Ajani JJ, Abbruzzese JL, Belt RJ, Dakhil SR, Dubovsky D, Graham S, Pilat S, Winn R, Levin B. Pazdur R, et al. Among authors: abbruzzese jl. Cancer. 1992 Oct 15;70(8):2073-6. doi: 10.1002/1097-0142(19921015)70:8<2073::aid-cncr2820700810>3.0.co;2-a. Cancer. 1992. PMID: 1394037 Clinical Trial.

6

Phase II study of didemnin B in advanced colorectal cancer.

Jones DV Jr, Ajani JA, Blackburn R, Daugherty K, Levin B, Patt YZ, Abbruzzese JL. Jones DV Jr, et al. Among authors: abbruzzese jl. Invest New Drugs. 1992 Aug;10(3):211-3. doi: 10.1007/BF00877248. Invest New Drugs. 1992. PMID: 1428730 Clinical Trial.

7

Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.

Hubbard KP, Pazdur R, Ajani JA, Braud E, Blaustein A, King M, Llenado-Lee M, Winn R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: abbruzzese jl. Am J Clin Oncol. 1992 Dec;15(6):524-7. Am J Clin Oncol. 1992. PMID: 1449117 Clinical Trial.

8

Phase II study of gemcitabine in advanced colorectal adenocarcinoma.

Moore DF Jr, Pazdur R, Daugherty K, Tarassoff P, Abbruzzese JL. Moore DF Jr, et al. Among authors: abbruzzese jl. Invest New Drugs. 1992 Nov;10(4):323-5. doi: 10.1007/BF00944189. Invest New Drugs. 1992. PMID: 1487408 Clinical Trial.

9

Synergistic cytotoxicity using 2'-deoxy-5-azacytidine and cisplatin or 4-hydroperoxycyclophosphamide with human tumor cells.

Frost P, Abbruzzese JL, Hunt B, Lee D, Ellis M. Frost P, et al. Among authors: abbruzzese jl. Cancer Res. 1990 Aug 1;50(15):4572-7. Cancer Res. 1990. PMID: 1695122

10

Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas.

Ajani JA, Pazdur R, Winn RJ, Abbruzzese JL, Levin B, Belt R, Young J, Patt YZ, Krakoff IH. Ajani JA, et al. Among authors: abbruzzese jl. Invest New Drugs. 1991 Nov;9(4):369-71. doi: 10.1007/BF00183584. Invest New Drugs. 1991. PMID: 1804816 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

501 results

Search Page

Filters